相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
FOXP3
- 级别:
FOXP3 Antibody
- 目录编号:
FOXP3 Antibody
- 克隆性:
单克隆
- 抗原来源:
小鼠
- 保质期:
FOXP3 Antibody
- 抗体英文名:
Dazzle™ 594 anti-human FOXP3 Antibody-PE
- 抗体名:
FOXP3 Antibody
- 标记物:
PE
- 宿主:
小鼠
- 适应物种:
人
- 免疫原:
FOXP3 Antibody
- 亚型:
FOXP3 Antibody
- 形态:
FOXP3 Antibody
- 应用范围:
ICFC
- 保存条件:
2-8℃
- 浓度:
FOXP3 Antibody
- 规格:
25 tests/100 tests
| 规格: | 25 tests | 产品价格: | ¥2900.0 |
|---|---|---|---|
| 规格: | 100 tests | 产品价格: | ¥6900.0 |
Dazzle™ 594 anti-human FOXP3 Antibody-PE详细如下:
Description :FOXP3 is a 50-55 kD transcription factor, also known as Forkhead box protein P3, Scurfin,JM2, or IPEX. It is proposed to be a master regulatory gene and more specific marker of Tregulatory cells than most cell surface markers (such as CD4 and CD25). Transducedexpression of FOXP3 in CD4 /CD25 cells has been shown to induce GITR, CD103, andCTLA4 and impart a T regulatory cell phenotype. FOXP3 is mutated in X-linked autoimmunityallergic dysregulation syndrome (XLAAD or IPEX) in humans and in "scurfy" mice.Overexpression of FOXP3 has been shown to lead to a hypoactive immune state suggestingthat this transcriptional factor is a central regulator of T cell activity. In human, unlike in mouse,two isoforms of FOXP3 have been reported: one (FOXP3) corresponding to the canonical fulllength sequence; the other (FOXP3 δ2) lacking exon 2. The 206D antibody recognizes humanFOXP3 epitope in the region of amino acids 105-235.
Verified Reactivity :Human
Reported Reactivity :Baboon, Cynomolgus, Rhesus, Pigtailed Macaque
Antibody Type :Monoclonal
Host Species :Mouse
Immunogen :Full-length FOXP3 protein
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation :The antibody was purified by affinity chromatography and conjugated with PE/Dazzle™ 594 underoptimal conditions.
Concentration :Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :ICFC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by intracellular flow cytometry using our TrueNuclear™ Transcription Factor Staining Protocol. For flow cytometric staining, the suggested useof this reagent is 5 µl per million cells in 100 µl staining volume. It is recommended that the reagentbe titrated for optimal performance for each application.
* PE/Dazzle™ 594 has a maximum excitation of 566 nm and a maximum emission of 610 nm.
Excitation Laser :Blue Laser (488 nm)、Green Laser (532 nm)、Yellow-Green Laser (561 nm)
Description :FOXP3 is a 50-55 kD transcription factor, also known as Forkhead box protein P3, Scurfin,JM2, or IPEX. It is proposed to be a master regulatory gene and more specific marker of Tregulatory cells than most cell surface markers (such as CD4 and CD25). Transducedexpression of FOXP3 in CD4 /CD25 cells has been shown to induce GITR, CD103, andCTLA4 and impart a T regulatory cell phenotype. FOXP3 is mutated in X-linked autoimmunityallergic dysregulation syndrome (XLAAD or IPEX) in humans and in "scurfy" mice.Overexpression of FOXP3 has been shown to lead to a hypoactive immune state suggestingthat this transcriptional factor is a central regulator of T cell activity. In human, unlike in mouse,two isoforms of FOXP3 have been reported: one (FOXP3) corresponding to the canonical fulllength sequence; the other (FOXP3 δ2) lacking exon 2. The 206D antibody recognizes humanFOXP3 epitope in the region of amino acids 105-235.
Verified Reactivity :Human
Reported Reactivity :Baboon, Cynomolgus, Rhesus, Pigtailed Macaque
Antibody Type :Monoclonal
Host Species :Mouse
Immunogen :Full-length FOXP3 protein
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation :The antibody was purified by affinity chromatography and conjugated with PE/Dazzle™ 594 underoptimal conditions.
Concentration :Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysis online tool.)
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :ICFC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by intracellular flow cytometry using our TrueNuclear™ Transcription Factor Staining Protocol. For flow cytometric staining, the suggested useof this reagent is 5 µl per million cells in 100 µl staining volume. It is recommended that the reagentbe titrated for optimal performance for each application.
* PE/Dazzle™ 594 has a maximum excitation of 566 nm and a maximum emission of 610 nm.
Excitation Laser :Blue Laser (488 nm)、Green Laser (532 nm)、Yellow-Green Laser (561 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Roncador G, et al. 2005. Eur. J. Immunol. 35:1681.(IHC)
2. Yang ZZ, et al. 2006. Blood 107:3639.
3. Liu W, et al. 2006. J. Exp. Med. 203:1701.PubMed
4. Bollyky PL, et al. 2007. J. Immunol. 179:744.
5. Bell MP, et al. 2007. J. Immunol. 179:1893.
6. Tran DQ, et al. 2007. Blood doi:10.1182/blood-2007-06-094656. PubMed
7. Gao Q,et al.2007.J Clin Oncol.25:2586.(IHC) PubMed
8. Pillai V,et al. 2008. Blood 111:463. PubMed
9. Zheng Y, et al. 2008. J. Immunol. 181:1683. PubMed
10. Zonios DI, et al. 2008.Blood112:287. PubMed
11. Kavanagh B, et al. 2008. Blood. PubMed
12. Nevala WK, et al. 2009. Clin Cancer Res. 15:1931. PubMed
13. Grant J, et al. 2009. Cytometry B Clin Cytom. 76:69. PubMed
14. Nigam P, et al. 2010. J. Immunol. 184:1690. PubMed
15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (ICFC) PubMed
16. Hartigan-O'Connor DJ,et al.2007.J Exp Med.204:2679. PubMed
17. Raghaven S, et al. 2009. Ann Rheum Dis. 68:1908. PubMed
18. Hodi FS, et al. 2014. Cancer Immunol Res. 2:632.(IHC) PubMed
19. Sziros E, et al. 2015. Clin Cancer Res. 21:2840.(IHC) PubMed
Product Citations:
1. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
2. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
3. Ackerley CG, et al. 2022. Front Immunol. 13:972170. PubMed
4. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
1. Roncador G, et al. 2005. Eur. J. Immunol. 35:1681.(IHC)
2. Yang ZZ, et al. 2006. Blood 107:3639.
3. Liu W, et al. 2006. J. Exp. Med. 203:1701.PubMed
4. Bollyky PL, et al. 2007. J. Immunol. 179:744.
5. Bell MP, et al. 2007. J. Immunol. 179:1893.
6. Tran DQ, et al. 2007. Blood doi:10.1182/blood-2007-06-094656. PubMed
7. Gao Q,et al.2007.J Clin Oncol.25:2586.(IHC) PubMed
8. Pillai V,et al. 2008. Blood 111:463. PubMed
9. Zheng Y, et al. 2008. J. Immunol. 181:1683. PubMed
10. Zonios DI, et al. 2008.Blood112:287. PubMed
11. Kavanagh B, et al. 2008. Blood. PubMed
12. Nevala WK, et al. 2009. Clin Cancer Res. 15:1931. PubMed
13. Grant J, et al. 2009. Cytometry B Clin Cytom. 76:69. PubMed
14. Nigam P, et al. 2010. J. Immunol. 184:1690. PubMed
15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (ICFC) PubMed
16. Hartigan-O'Connor DJ,et al.2007.J Exp Med.204:2679. PubMed
17. Raghaven S, et al. 2009. Ann Rheum Dis. 68:1908. PubMed
18. Hodi FS, et al. 2014. Cancer Immunol Res. 2:632.(IHC) PubMed
19. Sziros E, et al. 2015. Clin Cancer Res. 21:2840.(IHC) PubMed
Product Citations:
1. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
2. Le X, et al. 2021. J Thorac Oncol. 16:583. PubMed
3. Ackerley CG, et al. 2022. Front Immunol. 13:972170. PubMed
4. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
文献支持
Dazzle™ 594 抗人 FOXP3 荧光标记PE 抗体
¥2900 - 6900










